Medite Cancer Diagnostics (MDIT) Q3 2017 Earnings

31DecConfirmed
May 17
Aug 17
Nov 17
Q3 2017
-0.09
-0.07
-0.06
-0.04

Details

Expected EPS
N/A
Actual EPS
-0.0896
Surprise EPS
-0.09
Surprise Percent
+∞%

Description

Medite Cancer Diagnostics (MDIT) has reported earnings of -0.0896 per share for Q3 2017.

0 Comments

Share your thoughts